Patent details

EP2105135 Title: Pharmaceutical compositions for treating cancer

Basic Information

Publication number:
EP2105135
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP090087560
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical compositions for treating cancer
French Title of Invention:
Compositions pharmaceutiques pour le traitement du cancer
German Title of Invention:
Pharmazeutische Zusammensetzungen zur Behandlung von Krebs
SPC Number:
92642

Dates

Filing date:
16/05/2003
Grant date:
22/10/2014
EP Publication Date:
22/10/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/09/2009
EP B1 Publication Date:
22/10/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/05/2023
Renunciation date:
Revocation date:
19/12/2016
Annulment date:

Owner

From:
16/05/2003
 
 

Name:
CELGENE CORPORATION
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/10/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Zeldis Jerome, B.
Address:
United States (US)

Priority

1

Priority Number:
380842 P
Priority Date:
17/05/2002
Priority Country:
United States (US)

2

Priority Number:
424600 P
Priority Date:
06/11/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/454;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2017/04
Publication date:
04/08/2017
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
201728
Publication date:
12/07/2017
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/05/2016
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages